Cantor Fitzgerald Maintains $18.0 Price Objective On Allscripts (MDRX), Maintains “Buy” Rating; Bonanza Creek Energy (BCEI) Shorts Down By 15.15%

February 16, 2018 - By Jerrie Dane

Among 26 analysts covering Allscripts-Misys Healthcare (NASDAQ:MDRX), 12 have Buy rating, 1 Sell and 13 Hold. Therefore 46% are positive. Allscripts-Misys Healthcare has $19.0 highest and $12 lowest target. $15.58’s average target is 4.99% above currents $14.84 stock price. Allscripts-Misys Healthcare had 60 analyst reports since August 5, 2015 according to SRatingsIntel. The firm has “Market Perform” rating by Leerink Swann given on Monday, June 19. Topeka Capital Markets maintained it with “Hold” rating and $14 target in Wednesday, August 5 report. Morgan Stanley maintained it with “Underweight” rating and $12 target in Monday, August 7 report. The firm has “Overweight” rating given on Tuesday, November 17 by JP Morgan. The stock has “Neutral” rating by Dougherty & Company on Friday, December 2. The stock of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) earned “Buy” rating by Jefferies on Friday, August 25. The stock of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) earned “Hold” rating by KeyBanc Capital Markets on Wednesday, September 20. Wells Fargo upgraded Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) on Monday, March 27 to “Outperform” rating. The rating was upgraded by Cantor Fitzgerald on Tuesday, August 15 to “Overweight”. The stock of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) has “Buy” rating given on Friday, October 27 by Jefferies.

Bonanza Creek Energy Incorporated (NYSE:BCEI) had a decrease of 15.15% in short interest. BCEI’s SI was 475,100 shares in February as released by FINRA. Its down 15.15% from 559,900 shares previously. With 729,200 avg volume, 1 days are for Bonanza Creek Energy Incorporated (NYSE:BCEI)’s short sellers to cover BCEI’s short positions. The stock increased 1.48% or $0.38 during the last trading session, reaching $26.12. About 380,937 shares traded or 8.30% up from the average. Bonanza Creek Energy, Inc. (NYSE:BCEI) has declined 89.11% since February 16, 2017 and is downtrending. It has underperformed by 105.81% the S&P500.

Bonanza Creek Energy, Inc., an independent oil and natural gas company, engages in the exploration, development, and production of onshore oil and related liquids-rich natural gas in the United States. The company has market cap of $534.25 million. The companyÂ’s oil and liquids-weighted assets are located primarily in the Wattenberg Field in Colorado; and the Dorcheat Macedonia Field in southern Arkansas. It currently has negative earnings. It also owns and operates oil-producing assets in the North Park Basin in Colorado; and the McKamie Patton Field in southern Arkansas.

Among 18 analysts covering Bonanza Creek Energy (NYSE:BCEI), 2 have Buy rating, 5 Sell and 11 Hold. Therefore 11% are positive. Bonanza Creek Energy had 48 analyst reports since July 28, 2015 according to SRatingsIntel. The company was initiated on Tuesday, October 13 by JP Morgan. The rating was maintained by Topeka Capital Markets with “Buy” on Monday, October 5. Topeka Capital Markets maintained Bonanza Creek Energy, Inc. (NYSE:BCEI) rating on Tuesday, July 28. Topeka Capital Markets has “Buy” rating and $18 target. The firm has “Sell” rating by Wunderlich given on Tuesday, August 2. Topeka Capital Markets maintained it with “Hold” rating and $3 target in Friday, May 6 report. The rating was downgraded by Credit Suisse on Tuesday, March 8 to “Neutral”. KeyBanc Capital Markets maintained Bonanza Creek Energy, Inc. (NYSE:BCEI) on Tuesday, September 5 with “Hold” rating. The firm has “In-Line” rating by Imperial Capital given on Wednesday, March 2. The company was initiated on Thursday, October 1 by Bank of America. On Wednesday, June 21 the stock rating was maintained by BMO Capital Markets with “Hold”.

Investors sentiment decreased to 1.16 in Q3 2017. Its down 0.29, from 1.45 in 2017Q2. It is negative, as 22 investors sold Allscripts Healthcare Solutions, Inc. shares while 72 reduced holdings. 44 funds opened positions while 65 raised stakes. 195.75 million shares or 0.88% less from 197.48 million shares in 2017Q2 were reported. 291,724 are owned by Alliancebernstein L P. Sentinel Asset Incorporated has invested 0.24% in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). Menta Capital Ltd Llc holds 0.12% or 58,527 shares in its portfolio. Maryland-based Price T Rowe Assocs Md has invested 0% in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). American Int Inc holds 0.02% or 491,321 shares. California State Teachers Retirement System has invested 0.01% of its portfolio in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). Deutsche Savings Bank Ag holds 1.39M shares. Macquarie Group Inc stated it has 0% of its portfolio in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). Millennium Mgmt Ltd Liability Company reported 4.98M shares or 0.11% of all its holdings. Retail Bank Of Montreal Can holds 0.01% or 799,973 shares in its portfolio. Next Gp holds 640 shares. Cortina Asset Management Ltd accumulated 0.48% or 814,120 shares. 997,009 are owned by Janney Mgmt Ltd Limited Liability Company. Guggenheim Capital Llc accumulated 83,663 shares. Tower Research Cap Ltd Liability (Trc) has 0.04% invested in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX).

Allscripts Healthcare Solutions, Inc. provides information technology and services to healthcare organizations in the United States, Canada, and internationally. The company has market cap of $2.68 billion. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions. It currently has negative earnings. The companyÂ’s Clinical and Financial Solutions segment provides integrated clinical software applications and financial and information solutions, which primarily include EHR-related, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, revenue cycle management, training, and electronic claims administration services.

Since September 14, 2017, it had 0 insider purchases, and 6 selling transactions for $974,699 activity. 15,000 shares valued at $215,292 were sold by Black Paul on Thursday, December 14. Farley Brian also sold $67,607 worth of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) on Thursday, September 14. Poulton Richard J. also sold $203,433 worth of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) on Friday, September 15.

The stock increased 2.70% or $0.39 during the last trading session, reaching $14.84. About 2.23 million shares traded or 8.92% up from the average. Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) has declined 8.32% since February 16, 2017 and is downtrending. It has underperformed by 25.02% the S&P500.